Finance

Beta
Lists
CAI:NASDAQ
Caris Life Sciences Inc
$16.49
-4.57%
(-0.79) 1D
$16.24
-1.52% (-0.25)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAI...
Open
$17.29
High
$17.39
Low
$16.16
Mkt. cap
4.66B
Avg. vol.
2.87M
Volume
2.74M
52-wk high
$42.50
52-wk low
$14.19
EPS
-$1.47
Shares outstanding
282.68M
No. of employees
2K
Open
$17.29
High
$17.39
Low
$16.16
Mkt. cap
4.66B
Avg. vol.
2.87M
Volume
2.74M
52-wk high
$42.50
52-wk low
$14.19
EPS
-$1.47
Shares outstanding
282.68M
No. of employees
2K
Analyst outlook
Analyst Ratings
Based on 13 analysts giving stock ratings to CAI in the past 3 months
Strong Buy
Buy
10
Hold
3
Sell
0
12 month forecast
Based on 13 Wall Street analysts offering 12 month price targets for CAI in the last 3 months.
Highest
Current $16.49
$36.00 (+118.31%)
Average
$27.92 (+69.31%)
Lowest
$21.00 (+27.35%)
News stories
From sources across the web
About Caris Life Sciences Inc
CEO-
Employees1.85K
Founded2008
HeadquartersIrving, Texas, United States
SectorBiotechnology
Websitecarislifesciences.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
/ -$0.02
0.00%miss
Revenue / Est. (USD)
216.17M / 209.67M
+3.10%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
181.40M
216.83M
292.89M
216.17M
Cost of goods sold
67.71M
69.33M
70.10M
74.83M
Cost of revenue
67.71M
69.33M
70.10M
74.83M
Research and development expenses
25.05M
21.62M
29.82M
31.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
106.63M
93.24M
104.55M
104.75M
Operating expense
131.67M
114.86M
134.37M
136.07M
Total operating expenses
199.39M
184.19M
204.48M
210.89M
Operating income
-17.99M
32.64M
88.41M
5.28M
Other non operating income
-18.28M
-2.17M
-148.00K
49.00K
EBT including unusual items
-71.79M
24.32M
81.96M
-644.00K
EBT excluding unusual items
-53.86M
24.32M
83.92M
-644.00K
Income tax expense
-
-
-
-134.00K
Effective tax rate
-
-
-
20.81%
Other operating expenses
-
-
-
-
Net income
-71.79M
24.32M
81.96M
-510.00K
Net profit margin
-39.58%
11.22%
27.98%
-0.24%
Earnings per share
-1.11
0.08
0.28
-
Interest and investment income
1.62M
7.36M
7.02M
6.83M
Interest expense
-19.21M
-13.51M
-11.36M
-12.81M
Net interest expenses
-17.59M
-6.15M
-4.34M
-5.98M
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.58M
37.51M
92.70M
10.35M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer